This site uses cookies in order to provide you with the best possible service.

Read Our Cookie Policy Agree
covid

Frequently Asked Questions (FAQ) → Click here

Specialist fields (in extracts)

Hematology:

- Diagnostics and treatment of malignant haematological diseases (acute leukaemia, myelodysplastic syndrome, chronic myeloproliferative neoplasia, malignant lymphomas, multiple myeloma, benign blood diseases)

- Autologous and allogeneic stem cell transplantation

- Hematological diagnostics including FISH, flow cytometry, cytology

Oncology:

- Diagnostics and pharmalogical treatment of all solid organ malignancies (including lung cancer, malignancies of the gastrointestine, malignancies of the central nervous system, breast cancer and gynecological malignancies, head-neck cancer)

Curriculum vitae (in extracts)

December 2000
Medical license (Approbation)
2000-2005
Fellowship at the University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology and Immunology
2005-2012
Fellowship at the University Hospital Würzburg, department of Internal Medicine II
2008
Specialization in Internal Medicine: Attending physician at the University Hospital Würzburg, department of Internal Medicine II
2009
Specialization in hematology and medical oncology at the University Hospital Würzburg, department of Internal Medicine II
2012-2019
Head of division for allogeneic stem cell transplantation at the University Hospital Würzburg, department of Internal Medicine II
January 2015
Venia legendi (Habilitation) for Internal Medicine at the University of Würzburg awarded for „the donor immune system as basis for cellular immuno therapies against infections and hematological malignancies”
Since October 2019
Head of Department Hematology, Oncology and Immunology at the Helios Hospital Duisburg

Extra information

Ongoing Research Projects:

Prophylactic Application of donor-derived Central memory T lymphocytes after allogeneic hematopoetic progenitor cell transplantation to prevent infectious complications (PACT): A prospective, first in man, open Phase I/IIa clinical trial

Advanced Concepts in Cellular Immune Control of Cytomegalovirus – P09 Personalized medicine – Risk stratification and prevention of HCMV-related disease in transplant patients based on MHC-I peptidome analysis (Deutsche Forschungsgemeinschaft)

Memberships

  • European Society for Blood and Marrow Transplantation (EBMT)
  • Deutsche Arbeitsgemeinschaften für Knochenmark- und Blutstammzelltransplantation e.V. (DAG-KBT)
  • Studienallianz Leukämie (SAL)

Send Request

We speak german, english, russian, arabic and french